[SCHEDULE 13G/A] Centessa Pharmaceuticals plc American SEC Filing
Adage Capital Management, together with principals Robert Atchinson and Phillip Gross, reports beneficial ownership of 8,403,000 ordinary shares of Centessa Pharmaceuticals, representing 6.29% of the outstanding class based on 133,618,774 shares. The shares are ordinary shares underlying ADSs traded under ticker CNTA. The filing shows no sole voting or dispositive power 鈥� all voting and dispositive rights are reported as shared 鈥� and includes a certification that the securities are held in the ordinary course of business and not for the purpose of changing control. The statement contains ownership details and reporting person roles but does not disclose any transaction terms or plans.
Adage Capital Management, insieme ai partner Robert Atchinson e Phillip Gross, dichiara la titolarit脿 beneficiaria di 8,403,000 azioni ordinarie di Centessa Pharmaceuticals, corrispondenti al 6.29% della classe in circolazione su un totale di 133,618,774 azioni. Le azioni sono azioni ordinarie sottostanti ADS negoziate con il ticker CNTA. Il deposito indica nessun potere di voto o di disposizione esclusivo 鈥� tutti i diritti di voto e di disposizione sono riportati come condivisi 鈥� e contiene una certificazione che i titoli sono detenuti nell'ordinaria attivit脿 di impresa e non con l'intento di cambiare il controllo. La dichiarazione include dettagli sulla propriet脿 e sui ruoli delle persone che rendono il rapporto, ma non rivela termini di transazione n茅 piani.
Adage Capital Management, junto con los socios Robert Atchinson y Phillip Gross, informa la propiedad beneficiaria de 8,403,000 acciones ordinarias de Centessa Pharmaceuticals, que representan el 6.29% de la clase en circulaci贸n sobre un total de 133,618,774 acciones. Las acciones son acciones ordinarias subyacentes a ADS negociados bajo el ticker CNTA. La presentaci贸n indica ning煤n poder exclusivo de voto o disposici贸n 鈥� todos los derechos de voto y disposici贸n se declaran compartidos 鈥� e incluye una certificaci贸n de que los valores se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar el control. La declaraci贸n contiene detalles de propiedad y de las personas informantes, pero no revela t茅rminos de ninguna transacci贸n ni planes.
Adage Capital Management電� 欤检殧 鞚胳偓 Robert Atchinson 氚� Phillip Gross鞕� 頃粯 Centessa Pharmaceuticals鞚� 氤错喌欤� 8,403,000欤检棎 雽�頃� 鞁れ唽鞙犽ゼ 氤搓碃頃橂┌, 鞚措姅 齑� 133,618,774欤茧ゼ 旮办鞙茧 氚滍枆欤检嫕鞚� 6.29%鞐� 頃措嫻頃╇媹雼�. 頃措嫻 欤检嫕鞚� 韹办护 CNTA搿� 瓯半灅霅橂姅 ADS鞚� 旮办磮臧� 霅橂姅 氤错喌欤检瀰雼堧嫟. 氤搓碃靹滌棎電� 雼弲 鞚橁舶甓� 霕愲姅 觳橂秳甓岇澊 鞐嗢潓鞙茧 響滌嫓霅橃柎 鞛堨溂氅� 鈥� 氇摖 鞚橁舶甓岅臣 觳橂秳甓岇潃 瓿惦彊鞙茧 氤搓碃霅橃柎 鞛堨姷雼堧嫟 鈥� 鞚� 歃濌秾霌れ澊 靷梾鞚� 韱奠儊鞝� 氩旍渼鞐愳劀 氤挫湢霅橁碃 鞛堨溂氅� 歆�氚瓣秾 氤�瓴届潉 氇╈爜鞙茧 頃橃 鞎婋姅雼る姅 鞚胳鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 靹彪獏靹滌棎電� 靻岇湢 雮挫棴瓿� 氤搓碃鞚胳潣 鞐暊鞚� 韽暔霅橃柎 鞛堨溂雮�, 鞏措枲頃� 瓯半灅 臁瓣贝鞚措倶 瓿勴殟鞚� 瓿店皽頃橃 鞎婌姷雼堧嫟.
Adage Capital Management, conjointement avec les dirigeants Robert Atchinson et Phillip Gross, d茅clare la propri茅t茅 b茅n茅ficiaire de 8,403,000 actions ordinaires de Centessa Pharmaceuticals, repr茅sentant 6.29% de la classe en circulation sur la base de 133,618,774 actions. Les actions sont des actions ordinaires sous-jacentes 脿 des ADS cot茅es sous le ticker CNTA. Le d茅p么t indique aucun pouvoir exclusif de vote ou de disposition 鈥� tous les droits de vote et de disposition sont d茅clar茅s partag茅s 鈥� et comprend une certification que les titres sont d茅tenus dans le cours normal des affaires et non dans l'intention de changer le contr么le. La d茅claration contient des d茅tails sur la propri茅t茅 et les r么les des personnes d茅clarantes mais ne divulgue aucun terme de transaction ni aucun plan.
Adage Capital Management berichtet gemeinsam mit den Principals Robert Atchinson und Phillip Gross 眉ber das wirtschaftliche Eigentum an 8,403,000 Stammaktien von Centessa Pharmaceuticals, was 6.29% der ausstehenden Klasse auf Basis von 133,618,774 Aktien entspricht. Die Aktien sind Stammaktien, die ADS zugrunde liegen, welche unter dem Ticker CNTA gehandelt werden. Die Einreichung weist keine alleinigen Stimm- oder Verf眉gungsrechte aus 鈥� alle Stimm- und Verf眉gungsrechte werden als geteilt gemeldet 鈥� und enth盲lt eine Best盲tigung, dass die Wertpapiere im normalen Gesch盲ftsverlauf gehalten werden und nicht zum Zweck eines Kontrollwechsels. Die Erkl盲rung enth盲lt Eigentumsangaben und Angaben zu den meldenden Personen, nennt jedoch keine Transaktionsbedingungen oder Pl盲ne.
- Adage Capital and named principals beneficially own 8,403,000 shares, representing a material 6.29% stake in Centessa.
- The filing includes a certification that the holdings were acquired and are held in the ordinary course of business and not to change control.
- No sole voting or dispositive power is reported; all 8,403,000 shares are disclosed as subject to shared voting and dispositive authority.
Insights
TL;DR Institutional stake of 6.29% is materially sized but reported with shared control and no stated intent to change control.
Adage Capital and the named principals report beneficial ownership of 8,403,000 shares, equal to 6.29% of the class, calculated on an outstanding base of 133,618,774 shares. For investors, a >5% disclosure is material because it signals a meaningful economic position, but the filing also makes clear that voting and dispositive powers are shared and the holders certify the position is not intended to effect control. Absent additional transactions or statements of intent, this remains a disclosure of ownership rather than an activist or control move.
TL;DR The filing documents a sizeable passive stake with shared voting/dispositive power and an explicit certification against control-seeking.
The Schedule 13G/A identifies Adage Capital Management as the reporting entity and names Robert Atchinson and Phillip Gross as related reporting persons with managerial roles in the reporting structure. All 8,403,000 shares are reported with shared voting and dispositive authority, and the signatory certification states the securities are held in the ordinary course and not to influence control. From a governance perspective, the filing increases transparency about substantial ownership while signaling an absence of immediate governance actions or control initiatives.
Adage Capital Management, insieme ai partner Robert Atchinson e Phillip Gross, dichiara la titolarit脿 beneficiaria di 8,403,000 azioni ordinarie di Centessa Pharmaceuticals, corrispondenti al 6.29% della classe in circolazione su un totale di 133,618,774 azioni. Le azioni sono azioni ordinarie sottostanti ADS negoziate con il ticker CNTA. Il deposito indica nessun potere di voto o di disposizione esclusivo 鈥� tutti i diritti di voto e di disposizione sono riportati come condivisi 鈥� e contiene una certificazione che i titoli sono detenuti nell'ordinaria attivit脿 di impresa e non con l'intento di cambiare il controllo. La dichiarazione include dettagli sulla propriet脿 e sui ruoli delle persone che rendono il rapporto, ma non rivela termini di transazione n茅 piani.
Adage Capital Management, junto con los socios Robert Atchinson y Phillip Gross, informa la propiedad beneficiaria de 8,403,000 acciones ordinarias de Centessa Pharmaceuticals, que representan el 6.29% de la clase en circulaci贸n sobre un total de 133,618,774 acciones. Las acciones son acciones ordinarias subyacentes a ADS negociados bajo el ticker CNTA. La presentaci贸n indica ning煤n poder exclusivo de voto o disposici贸n 鈥� todos los derechos de voto y disposici贸n se declaran compartidos 鈥� e incluye una certificaci贸n de que los valores se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar el control. La declaraci贸n contiene detalles de propiedad y de las personas informantes, pero no revela t茅rminos de ninguna transacci贸n ni planes.
Adage Capital Management電� 欤检殧 鞚胳偓 Robert Atchinson 氚� Phillip Gross鞕� 頃粯 Centessa Pharmaceuticals鞚� 氤错喌欤� 8,403,000欤检棎 雽�頃� 鞁れ唽鞙犽ゼ 氤搓碃頃橂┌, 鞚措姅 齑� 133,618,774欤茧ゼ 旮办鞙茧 氚滍枆欤检嫕鞚� 6.29%鞐� 頃措嫻頃╇媹雼�. 頃措嫻 欤检嫕鞚� 韹办护 CNTA搿� 瓯半灅霅橂姅 ADS鞚� 旮办磮臧� 霅橂姅 氤错喌欤检瀰雼堧嫟. 氤搓碃靹滌棎電� 雼弲 鞚橁舶甓� 霕愲姅 觳橂秳甓岇澊 鞐嗢潓鞙茧 響滌嫓霅橃柎 鞛堨溂氅� 鈥� 氇摖 鞚橁舶甓岅臣 觳橂秳甓岇潃 瓿惦彊鞙茧 氤搓碃霅橃柎 鞛堨姷雼堧嫟 鈥� 鞚� 歃濌秾霌れ澊 靷梾鞚� 韱奠儊鞝� 氩旍渼鞐愳劀 氤挫湢霅橁碃 鞛堨溂氅� 歆�氚瓣秾 氤�瓴届潉 氇╈爜鞙茧 頃橃 鞎婋姅雼る姅 鞚胳鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 靹彪獏靹滌棎電� 靻岇湢 雮挫棴瓿� 氤搓碃鞚胳潣 鞐暊鞚� 韽暔霅橃柎 鞛堨溂雮�, 鞏措枲頃� 瓯半灅 臁瓣贝鞚措倶 瓿勴殟鞚� 瓿店皽頃橃 鞎婌姷雼堧嫟.
Adage Capital Management, conjointement avec les dirigeants Robert Atchinson et Phillip Gross, d茅clare la propri茅t茅 b茅n茅ficiaire de 8,403,000 actions ordinaires de Centessa Pharmaceuticals, repr茅sentant 6.29% de la classe en circulation sur la base de 133,618,774 actions. Les actions sont des actions ordinaires sous-jacentes 脿 des ADS cot茅es sous le ticker CNTA. Le d茅p么t indique aucun pouvoir exclusif de vote ou de disposition 鈥� tous les droits de vote et de disposition sont d茅clar茅s partag茅s 鈥� et comprend une certification que les titres sont d茅tenus dans le cours normal des affaires et non dans l'intention de changer le contr么le. La d茅claration contient des d茅tails sur la propri茅t茅 et les r么les des personnes d茅clarantes mais ne divulgue aucun terme de transaction ni aucun plan.
Adage Capital Management berichtet gemeinsam mit den Principals Robert Atchinson und Phillip Gross 眉ber das wirtschaftliche Eigentum an 8,403,000 Stammaktien von Centessa Pharmaceuticals, was 6.29% der ausstehenden Klasse auf Basis von 133,618,774 Aktien entspricht. Die Aktien sind Stammaktien, die ADS zugrunde liegen, welche unter dem Ticker CNTA gehandelt werden. Die Einreichung weist keine alleinigen Stimm- oder Verf眉gungsrechte aus 鈥� alle Stimm- und Verf眉gungsrechte werden als geteilt gemeldet 鈥� und enth盲lt eine Best盲tigung, dass die Wertpapiere im normalen Gesch盲ftsverlauf gehalten werden und nicht zum Zweck eines Kontrollwechsels. Die Erkl盲rung enth盲lt Eigentumsangaben und Angaben zu den meldenden Personen, nennt jedoch keine Transaktionsbedingungen oder Pl盲ne.
FAQ
How many Centessa (CNTA) shares does Adage Capital report owning?
What percentage of CNTA does the reported stake represent?
Does Adage Capital claim voting or dispositive control over the CNTA shares?
Are the Centessa shares held to seek control according to the filing?
Under what structure are the shares held by the reporting persons?
Are the reported shares ordinary shares or ADSs for CNTA?
